SCHEMBL19225804

SCHEMBL19225804

CNC(=O)CCCCCOC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.38
GAA P10253 2/20 0.38
LMNA P02545 1/20 0.38
HDAC1 Q13547 6/20 0.37
HDAC2 Q92769 5/20 0.37
HDAC3 O15379 4/20 0.37
HDAC8 Q9BY41 4/20 0.37
HDAC6 Q9UBN7 4/20 0.37
HDAC5 Q9UQL6 4/20 0.37
ALDH1A1 P00352 2/20 0.36
EPHX1 P07099 1/20 0.36
PDK2 Q15119 1/20 0.36
HDAC4 P56524 3/20 0.35
HDAC7 Q8WUI4 3/20 0.35
HDAC10 Q969S8 3/20 0.35
HDAC11 Q96DB2 3/20 0.35
HDAC9 Q9UKV0 3/20 0.35
HSP90AA1 P07900 1/20 0.35
FAAH O00519 1/20 0.34
NAMPT P43490 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13765205 0.84 LMNA (0.43) RECQLLMNAALDH1A1PDK2
SCHEMBL24239868 0.83 RECQL (0.44) RECQLGAAFAAHCNR1CNR2
SCHEMBL12361989 0.81 ALDH1A1 (0.44) RECQLGAALMNAHDAC1HDAC2
SCHEMBL19587044 0.79 FAAH (0.49) GAAFAAHCNR1CNR2
SCHEMBL23074409 0.78 TSHR (0.54) RECQLLMNAALDH1A1
SCHEMBL12333287 0.78 HDAC3 (0.55) RECQLGAALMNAHDAC1HDAC2
SCHEMBL6159056 0.78 HDAC3 (0.55) RECQLGAALMNAHDAC1HDAC2
SCHEMBL5909431 0.78 HDAC3 (0.55) RECQLGAALMNAHDAC1HDAC2
SCHEMBL5909483 0.78 HDAC3 (0.55) RECQLGAALMNAHDAC1HDAC2
SCHEMBL29315161 0.78 HDAC3 (0.55) RECQLGAALMNAHDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10774079-B2 Quinazoline derivative CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. (CN) 2020-09-15 US disclosed
US-10421754-B2 Quinazoline derivative CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. (CN) 2019-09-24 US disclosed
US-20170226099-A1 QUINAZOLINE DERIVATIVE CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. (CN) 2017-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10774079-B2 Quinazoline derivative H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, TOP2A, TOP1 RECQL 23/4885GAA 1700/4885LMNA 3065/4885
US-10421754-B2 Quinazoline derivative H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, TOP2A, TOP1 RECQL 23/4885GAA 1700/4885LMNA 3065/4885
US-20170226099-A1 QUINAZOLINE DERIVATIVE H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, TOP2A, TOP1 RECQL 23/4885GAA 1700/4885LMNA 3065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.